MedPath

A clinical study on Saamuthara chooranam for Eri Gunmam(Peptic ulcer disease)

Phase 2
Conditions
Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
Registration Number
CTRI/2019/05/019164
Lead Sponsor
Government Siddha Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients having symptoms of with

a)epigastric pain

b)heart burn

c)nausea

d)vomiting

e)belching

f)water brash

g)lose of weight

h)indigestion

i)bloating of abdomen

2.Patients who are willing to take upper gastro-interstinal

endoscopy

3.Patients who are willing to give blood specimen for laboratory investigation when required

Exclusion Criteria

1.Pregnancy

2.Lactating mother

3.Recent malignancy or radiation therapy

4.Gastro esophageal refulx disease

5.Pancreatitis

6.Inflammatory bowel disease

7.Acute hepatitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome is reduction in clinical symptoms of <br/ ><br>a)epigastric pain <br/ ><br>b)heart burn <br/ ><br>c)vomiting <br/ ><br>d)nausea <br/ ><br>e)belching <br/ ><br>f)indigestion <br/ ><br>g)bloating of abdomen <br/ ><br>h)water brashTimepoint: 45days
Secondary Outcome Measures
NameTimeMethod
1.Evaluation of pharmacological activity of saamuthara chooranam <br/ ><br>2.Evaluation of siddha parameters changes in Erikunmam during trial period <br/ ><br>3.Determination of safety profile of trial drug <br/ ><br>4.Study about the prevalence of Erikunmam in relation between diet and life styleTimepoint: 45days
© Copyright 2025. All Rights Reserved by MedPath